Pfizer

Pfizer will provide 100 million doses of its coronavirus vaccine if and when it is approved later this year under a “historic” deal with the government, President Trump said Wednesday, as three states and D.C. scrambled in the meantime to stanch the virus by mandating masks outside the home. Mr. Trump used a White House…

The U.S. has agreed to pay Pfizer Inc. and BioNTech SE nearly $2 billion to secure 100 million doses of their experimental Covid-19 vaccine to provide to Americans free of charge. Under the $1.95 billion agreement, the U.S. Department of Health and Human Services and the Defense Department will receive 100 million doses of the…

The Trump administration fast-tracked trial vaccines for the coronavirus Monday as states across the South and West buckled from the rapid spread of COVID-19, forcing California to close indoor dining, museums and theaters while Miami considers another lockdown. The Food and Drug Administration said it will speed the review of two vaccine candidates from pharmaceutical…

Pfizer (NYSE:PFE) has initiated Phase 3 clinical trials on vaccine candidates for preventing pneumonia, RSV and meningitis. 20-valent pneumococcal vaccine (20vPnC): Two studies, NCT04382326 and NCT04379713, will assess a four-dose series in healthy infants. The former is aimed at determining immunologic non-inferiority to Prevnar 13.  RSV vaccine (RSVpreF): Study NCT04424316 is assessing the vaccine in infants…

Click to get this free report Sanofi (SNY) : Free Stock Analysis Report Pfizer Inc. (PFE) : Free Stock Analysis Report Moderna, Inc. (MRNA) : Free Stock Analysis Report BioNTech SE Sponsored ADR (BNTX) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research